	EDIT	FBIO
OUTLOOK RATING 1..100	60	7
VALUATION overvalued / fair valued / undervalued 1..100	34 Fair valued	19 Undervalued
PROFIT vs RISK RATING 1..100	100	100
SMR RATING 1..100	99	14
PRICE GROWTH RATING 1..100	79	85
P/E GROWTH RATING 1..100	100	33
SEASONALITY SCORE 1..100	50	n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (19) in the Biotechnology industry is in the same range as EDIT (34). This means that FBIO’s stock grew similarly to EDIT’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EDIT (100). This means that FBIO’s stock grew similarly to EDIT’s over the last 12 months.

FBIO's SMR Rating (14) in the Biotechnology industry is significantly better than the same rating for EDIT (99). This means that FBIO’s stock grew significantly faster than EDIT’s over the last 12 months.

EDIT's Price Growth Rating (79) in the Biotechnology industry is in the same range as FBIO (85). This means that EDIT’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's P/E Growth Rating (33) in the Biotechnology industry is significantly better than the same rating for EDIT (100). This means that FBIO’s stock grew significantly faster than EDIT’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	EDIT	FBIO
RSI ODDS (%)	N/A	2 days ago 88%
Stochastic ODDS (%)	2 days ago 81%	3 days ago 85%
Momentum ODDS (%)	2 days ago 90%	4 days ago 84%
MACD ODDS (%)	2 days ago 88%	2 days ago 85%
TrendWeek ODDS (%)	2 days ago 90%	2 days ago 85%
TrendMonth ODDS (%)	2 days ago 89%	2 days ago 86%
Advances ODDS (%)	11 days ago 80%	N/A
Declines ODDS (%)	2 days ago 90%	2 days ago 82%
BollingerBands ODDS (%)	2 days ago 74%	2 days ago 82%
Aroon ODDS (%)	2 days ago 90%	2 days ago 90%

COMPARISON

Comparison

Oct 03, 2026

Stock price -- (EDIT: $2.52 vs. FBIO: $2.07)

Brand notoriety: EDIT and FBIO are both not notable

Both companies represent the Biotechnology industry

Current volume relative to the 65-day Moving Average: EDIT: 50% vs. FBIO: 55%

Market capitalization -- EDIT: $385.49M vs. FBIO: $72.37M

EDIT [@Biotechnology] is valued at $385.49M. FBIO’s [@Biotechnology] market capitalization is $72.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green while FBIO’s FA Score has 3 green FA rating(s).

EDIT’s FA Score: 0 green, 5 red.
FBIO’s FA Score: 3 green, 2 red.

According to our system of comparison, FBIO is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 3 TA indicator(s) are bullish while FBIO’s TA Score has 3 bullish TA indicator(s).

EDIT’s TA Score: 3 bullish, 6 bearish.
FBIO’s TA Score: 3 bullish, 5 bearish.

According to our system of comparison, FBIO is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -8.36% price change this week, while FBIO (@Biotechnology) price change was -9.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 09, 2026.

FBIO is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three

EDIT

Daily Signal:

Gain/Loss:

FBIO

Setup

Daily Signal:

Description

Gain/Loss:

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

Interesting Tickers

ETFs / NAME	Price $	Chg $	Chg %
		1 Day
RXD	15.27	0.45	+3.02%
ProShares UltraShort Health Care (RXD)
FDIF	41.71	-0.01	-0.02%
Fidelity Disruptors ETF (FDIF)
VKI	7.47	-0.01	-0.13%
Invesco Advantage Municipal Income Trust II
IBHL	24.33	-0.14	-0.56%
iShares iBonds 2032 Term High Yield and Income ETF (IBHL)
ICOW	41.78	-0.28	-0.67%
Pacer Developed Markets International Cash Cows 100 ETF (ICOW)

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with BEAM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then BEAM could also see price increases.

Ticker / NAME	Correlation To EDIT	1D Price Change %
EDIT	100%	-1.95%
BEAM - EDIT	66% Loosely correlated	-0.25%
CRBU - EDIT	64% Loosely correlated	-3.94%
PRME - EDIT	63% Loosely correlated	-2.13%
CRSP - EDIT	63% Loosely correlated	+0.22%
VYGR - EDIT	61% Loosely correlated	-0.19%
More